Viewing Study NCT05035368


Ignite Creation Date: 2025-12-24 @ 5:37 PM
Ignite Modification Date: 2025-12-25 @ 9:09 PM
Study NCT ID: NCT05035368
Status: WITHDRAWN
Last Update Posted: 2023-12-22
First Post: 2021-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes
Sponsor: Dompé Farmaceutici S.p.A
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type I Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type I diabetes View
None Insulin-resistance View
None Overweight View